指南与共识食管胃疾病与幽门螺杆菌胃肠动力与功能性疾病

嗜酸性粒细胞性食管炎的临床严重程度指数:制定、共识与未来方向

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
指南 / 共识 · Gastroenterology · 2022-05-20

国际多学科专家组基于组织学、内镜和症状文献,通过会议共识创建了嗜酸性粒细胞性食管炎严重程度指数(I-SEE),按0-6分轻度、7-14分中度、≥15分重度进行分级,并建议未来临床试验和常规实践验证完善。

要点

  • I-SEE根据症状、并发症及内镜和组织学特征评分,0-6分轻度、7-14分中度、≥15分重度。
  • 该指数可在常规门诊就诊时完成,旨在标准化疾病严重程度评估。
  • I-SEE需在未来临床试验和常规临床实践中验证和完善。

核心结论

  • 多学科专家团队迭代创建了临床可用的EoE严重程度评分系统I-SEE,通过标准化反映疾病严重程度的组分来指导管理。
  • I-SEE应使用未来临床试验和常规临床实践的数据进行验证和完善,以提高其利用度和功能性。

研究设计与样本

  • 国际多学科成人及儿童EoE研究人员和临床医生,以及非EoE过敏免疫学和胃肠病学专家组成3个团队,审查组织学、内镜和症状文献。
  • 指导委员会召开为期1天的虚拟会议,就各团队关于关键临床病理领域严重程度显著特征的意见达成共识。

主要发现

  • 将症状特征和并发症以及内镜和组织学检查中的炎症和纤维狭窄特征整理成简化评分系统I-SEE。
  • I-SEE可在常规门诊就诊时完成,使用0-6分轻度、7-14分中度、≥15分重度EoE的分值范围评估疾病严重程度。

关键数值与推荐

  • I-SEE评分0-6分为轻度EoE。
  • I-SEE评分7-14分为中度EoE。
  • I-SEE评分≥15分为重度EoE。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • I-SEE应使用未来临床试验和常规临床实践的数据进行验证和完善,以提高其利用度和功能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Disease activity and severity of eosinophilic esophagitis (EoE) dictate therapeutic options and management, but the decision-making process for determining severity varies among practitioners. To reduce variability in practice patterns and help clinicians monitor the clinical course of the disease in an office setting, we aimed to create an international consensus severity scoring index for EoE. METHODS: A multidisciplinary international group of adult and pediatric EoE researchers and clinicians, as well as non-EoE allergy immunology and gastroenterology experts, formed 3 teams to review the existing literature on histology, endoscopy, and symptoms of EoE in the context of progression and severity. A steering committee convened a 1-day virtual meeting to reach consensus on each team's opinion on salient features of severity across key clinicopathologic domains and distill features that would allow providers to categorize disease severity. RESULTS: Symptom features and complications and inflammatory and fibrostenotic features on both endoscopic and histologic examination were collated into a simplified scoring system-the Index of Severity for Eosinophilic Esophagitis (I-SEE)-that can be completed at routine clinic visits to assess disease severity using a point scale of 0-6 for mild, 7-14 for moderate, and ≥15 for severe EoE. CONCLUSIONS: A multidisciplinary team of experts iteratively created a clinically usable EoE severity scoring system denominated "I-SEE" to guide practitioners in EoE management by standardizing disease components reflecting disease severity beyond eosinophil counts. I-SEE should be validated and refined using data from future clinical trials and routine clinical practice to increase its utilization and functionality.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Dellon ES, Khoury P, Muir AB, et al. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology. 2022. PMID: 35606197. doi:10.1053/j.gastro.2022.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。